Paper17548243
Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
Stockler MR and 16 others. Lancet Oncol, 2007. Cited by 111 papers, by iCite.
Cite this record
ConductScience Library. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Papers, record 17548243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17548243
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
- PubMed
- Publication types
- Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antidepressive Agents | Major topic |
| Depressive Disorder | Major topic |
| Neoplasms | Major topic |
| Sertraline | Major topic |
| Aged | |
| Diagnostic and Statistical Manual of Mental Disorders | |
| Double-Blind Method | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Placebos | |
| Psychiatric Status Rating Scales | |
| Quality of Life | |
| Survival Rate | |
| Treatment Outcome |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04525924 | Feasibility of Adjunctive BLT for Amelioration of Fatigue in Chinese Cancer Patients Admitted to a Palliative Care Unit | Background |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 17613418 | Use of antidepressants for depression in patients with advanced cancer. | https://conductscience.org/library/papers/17613418 |
Source PubMed
Cited by50
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 111 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42889697 | Association between antidepressant exposure and prognosis in breast cancer: A systematic review and meta-analysis. | Oncol Lett | 2026 | https://conductscience.org/library/papers/42889697 | PubMed |
| 42852094 | Depression and shortened survival in patients with cancer: a neuroimmune framework for bidirectional pathogenesis and therapeutic interception. | Front Immunol | 2026 | https://conductscience.org/library/papers/42852094 | PubMed |
| 42653166 | Pharmacological Modulators of TCTP: Opportunities and Challenges for Drug Repurposing. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653166 | PubMed |
| 41071419 | Health-related quality-of-life outcomes with regorafenib in advanced gastric and esophagogastric junction cancer: results from the INTEGRATE trials. | Gastric Cancer | 2025 | https://conductscience.org/library/papers/41071419 | PubMed |
| 40551461 | The Impact of Antidepressants on Surgical Outcomes Among Patients With Abdominal Cancer and Comorbid Depression. | Psychooncology | 2025 | https://conductscience.org/library/papers/40551461 | PubMed |
| 40314846 | Depression increases cancer mortality by 23-83%: a meta-analysis of 65 studies across five major cancer types. | Geroscience | 2026 | https://conductscience.org/library/papers/40314846 | PubMed |
| 37963058 | Accuracy of oncologists' estimates of expected survival time in advanced cancer. | JNCI Cancer Spectr | 2023 | https://conductscience.org/library/papers/37963058 | PubMed |
| 37958295 | Symptom Clusters in Survivorship and Their Impact on Ability to Work among Cancer Survivors. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37958295 | PubMed |
| 36999619 | Antidepressants for the treatment of depression in people with cancer. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/36999619 | PubMed |
| 36275706 | Stress and cancer: The mechanisms of immune dysregulation and management. | Front Immunol | 2022 | https://conductscience.org/library/papers/36275706 | PubMed |
| 35454890 | A New Approach to Understanding Cancer-Related Fatigue: Leveraging the 3P Model to Facilitate Risk Prediction and Clinical Care. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35454890 | PubMed |
| 35406105 | A Molecular Approach to Understanding the Role of Diet in Cancer-Related Fatigue: Challenges and Future Opportunities. | Nutrients | 2022 | https://conductscience.org/library/papers/35406105 | PubMed |
| 35269853 | Complex Effects of Sertraline and Citalopram on In Vitro Murine Breast Cancer Proliferation and on In Vivo Progression and Anxiety Level. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35269853 | PubMed |
| 34508247 | Stress and cancer: mechanisms, significance and future directions. | Nat Rev Cancer | 2021 | https://conductscience.org/library/papers/34508247 | PubMed |
| 34159294 | Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer. | JNCI Cancer Spectr | 2021 | https://conductscience.org/library/papers/34159294 | PubMed |
| 33844082 | Relationship between sleep disturbance, symptoms, and alcohol use in breast cancer survivors attending Sydney Cancer Survivorship Clinic. | Support Care Cancer | 2021 | https://conductscience.org/library/papers/33844082 | PubMed |
| 32642951 | What happens to cancer survivors attending a structured cancer survivorship clinic? Symptoms, quality of life and lifestyle changes over the first year at the Sydney Cancer Survivorship Centre clinic. | Support Care Cancer | 2021 | https://conductscience.org/library/papers/32642951 | PubMed |
| 32164823 | The Palliative Care of Patients With Incurable Cancer. | Dtsch Arztebl Int | 2020 | https://conductscience.org/library/papers/32164823 | PubMed |
| 32147571 | A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures. | Contemp Clin Trials | 2020 | https://conductscience.org/library/papers/32147571 | PubMed |
| 31302766 | The efficacy of placebo for the treatment of cancer-related fatigue: a systematic review and meta-analysis. | Support Care Cancer | 2020 | https://conductscience.org/library/papers/31302766 | PubMed |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| ISRCTN | ISRCTN72466475 |
Source ISRCTN
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17548243
GET https://conductscience.org/api/papers/v1/17548243/cited_by?page=2